Literature DB >> 29799416

An update on physical health and economic consequences of overweight and obesity.

Dinh-Toi Chu1, Nguyen Thi Minh Nguyet2, Thien Chu Dinh3, Nguyen Vu Thai Lien4, Khanh-Hoang Nguyen5, Vo Truong Nhu Ngoc4, Yang Tao6, Le Hoang Son7, Duc-Hau Le8, Vu Bich Nga9, Adam Jurgoński10, Quoc-Hung Tran11, Pham Van Tu12, Van-Huy Pham13.   

Abstract

Overweight and obesity (OW and OB) have been on the increase globally and posed health risks to the world's population of all ages, including pre-born babies, children, adolescents, adults and elderly people, via their comorbid conditions. Excellent examples of comorbidities associated with obesity include cancer, cardiovascular diseases (CVD) and type 2 diabetes mellitus (T2DM). In this article, we aimed to review and update scientific evidence regarding the relationships between obesity and its common physical health consequences, including CVD, T2DM, hypertension, ischemic stroke, cancer, dyslipidemia and reproductive disorders. In addition, the economic burden of OW and OB will be discussed. Abundant evidence is found to support the associations between obesity and other diseases. In general, the odd ratios, risk ratios or hazard ratios are often higher in OW and OB people than in the normal-weight ones. However, the molecular mechanism of how OW and OB induce the development of other diseases has not been fully understood. Figures also showed that obesity and its-related disorders exert enormous pressure on the economy which is projected to increase. This review highlights the fact that obesity can lead to numerous lethal health problems; therefore, it requires a lot of economic resources to fight against this epidemic.
Copyright © 2018 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Economic burden; Metabolic disorder; Obesity; Overweight; Physical health consequences

Mesh:

Year:  2018        PMID: 29799416     DOI: 10.1016/j.dsx.2018.05.004

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  29 in total

1.  14-Deoxygarcinol improves insulin sensitivity in high-fat diet-induced obese mice via mitigating NF-κB/Sirtuin 2-NLRP3-mediated adipose tissue remodeling.

Authors:  Jia-Li Chen; Zhe-Ling Feng; Fei Zhou; Ruo-Han Lou; Cheng Peng; Yang Ye; Li-Gen Lin
Journal:  Acta Pharmacol Sin       Date:  2022-08-09       Impact factor: 7.169

Review 2.  Obesity: a neuroimmunometabolic perspective.

Authors:  Chelsea M Larabee; Oliver C Neely; Ana I Domingos
Journal:  Nat Rev Endocrinol       Date:  2019-11-27       Impact factor: 43.330

3.  Hypothalamic-pituitary-adrenal axis attenuation and obesity risk in sexually abused females.

Authors:  Jacinda C Li; Molly A Hall; Idan Shalev; Hannah M C Schreier; Tomás González Zarzar; Isabel Marcovici; Frank W Putnam; Jennie G Noll
Journal:  Psychoneuroendocrinology       Date:  2021-05-12       Impact factor: 4.693

Review 4.  How we decide what to eat: Toward an interdisciplinary model of gut-brain interactions.

Authors:  Hilke Plassmann; Daniela Stephanie Schelski; Marie-Christine Simon; Leonie Koban
Journal:  Wiley Interdiscip Rev Cogn Sci       Date:  2021-05-11

5.  Efficiently Anti-Obesity Effects of Unsaturated Alginate Oligosaccharides (UAOS) in High-Fat Diet (HFD)-Fed Mice.

Authors:  Shangyong Li; Ningning He; Linna Wang
Journal:  Mar Drugs       Date:  2019-09-17       Impact factor: 5.118

Review 6.  The Effects of Adipocytes on the Regulation of Breast Cancer in the Tumor Microenvironment: An Update.

Authors:  Dinh-Toi Chu; Thuy Nguyen Thi Phuong; Nguyen Le Bao Tien; Dang-Khoa Tran; Tran-Thuy Nguyen; Vo Van Thanh; Thuy Luu Quang; Le Bui Minh; Van Huy Pham; Vo Truong Nhu Ngoc; Kushi Kushekhar; Thien Chu-Dinh
Journal:  Cells       Date:  2019-08-08       Impact factor: 6.600

7.  Risk analysis of systemic levels of estrogen and adipokines as well as estrogen receptors from PBMCs in childbearing and perimenopausal women with obesity.

Authors:  Huijuan Fan; Shujiao Chen; Bizhen Gao; Shanshan Ding; Qiang Zhao; Candong Li; Tetsuya Asakawa
Journal:  Diabetes Metab Syndr Obes       Date:  2019-08-01       Impact factor: 3.168

8.  The Vagus Nerve and Spleen: Influence on White Adipose Mass and Histology of Obese and Non-obese Rats.

Authors:  Joice Cristina Kuchler; Bruna Schumaker Siqueira; Vanessa Marieli Ceglarek; Fernanda Vigilato Chasko; Isllany Carvalho Moura; Bruna Fatima Sczepanhak; Jean Franciesco Vettorazzi; Sandra Lucinei Balbo; Sabrina Grassiolli
Journal:  Front Physiol       Date:  2021-06-25       Impact factor: 4.566

Review 9.  Gender medicine: Lessons from COVID-19 and other medical conditions for designing health policy.

Authors:  Yossy Machluf; Yoram Chaiter; Orna Tal
Journal:  World J Clin Cases       Date:  2020-09-06       Impact factor: 1.337

Review 10.  Is It Time to Use Probiotics to Prevent or Treat Obesity?

Authors:  Andrea Brusaferro; Rita Cozzali; Ciriana Orabona; Anna Biscarini; Edoardo Farinelli; Elena Cavalli; Ursula Grohmann; Nicola Principi; Susanna Esposito
Journal:  Nutrients       Date:  2018-11-01       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.